Full Text
PRS13 COST-UTILITY ANALYSIS OF MACITENTAN IN COMPARISON WITH BOSENTAN IN PULMONARY ATRIAL HYPERTENSION (PAH)

Abstract

Authors

M. Nosrati M. Afzali N. Ashrafi Shahmirzadi P. Zaboli H. Rouhani Z. Ghasemi Achachloui H. Hamedifar

Back to Volume 22, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×